caladrius biosciences stock

Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company with multiple technology platforms targeting select cardiovascular indications and autoimmune diseases. View real-time stock prices and stock quotes for a full financial overview.

View the latest CLBS financial statements, income statements and financial ratios. View Caladrius Biosciences Inc CLBS investment & stock information. From an enhanced free experience to professional stock picking - we have a great plan for you. Caladrius Biosciences, Inc. CLBS 1.86 0.03 (1.86%).

Find the latest Caladrius Biosciences, Inc. (CLBS) stock quote, history, news and other vital information to help you with your stock trading and investing. View daily, weekly or monthly format back to when Caladrius Biosciences, Inc. stock was issued. 0.07 (3.83%) DATA AS OF Jun 19, 2020. Get the latest Caladrius Biosciences Inc CLBS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. View clbs business summary and other industry information. Read More Its product pipeline includes CLBS12, CLBS14, CLBS16, and CLBS03. Caladrius Biosciences Inc. analyst estimates by MarketWatch. Since then, CLBS stock has decreased by 21.4% and is now trading at $1.76.

1.75. CLBS Caladrius Biosciences, Inc. Common Stock.

Caladrius Biosciences, Inc. Common Stock, also called Caladrius Biosciences, is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. View today's stock price, news and analysis for Caladrius Biosciences Inc. (CLBS).

CLBS | Complete Caladrius Biosciences Inc. stock news by MarketWatch.

Follow 10.45K followers Caladrius Biosciences, Inc. | NASDAQ.

Business Description. Caladrius Biosciences' stock was trading at $2.24 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization.

Caladrius Biosciences Inc. annual stock financials by MarketWatch. Caladrius Biosciences, Inc. (CLBS) Quote Overview » More Research » Caladrius Biosciences, Inc. (CLBS) Broker Recommendations Brokerage Recommendations Current ABR Caladrius Biosciences Inc. company facts, information and stock details by MarketWatch.

Latest News. Discover historical prices for CLBS stock on Yahoo Finance. View CLBS revenue estimates and earnings estimates, as well as analyst recommendations.

Premium. Caladrius Biosciences, Inc. Common Stock (CLBS) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Data is currently not available. $1.76. Read More Its product pipeline includes CLBS12, CLBS14, CLBS16, and CLBS03. Find the latest Caladrius Biosciences, Inc. (CLBS) stock discussion in Yahoo Finance's forum. Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company developing cellular therapies designed to reverse, not manage, disease. Caladrius Biosciences, Inc. Common Stock (CLBS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Caladrius Biosciences to Present on CLBS119 for COVID-19 Induced Lung Damage at the BioNJ COVID-19 Rapid Fire Research Showcase May 28, 2020 Caladrius Biosciences Closes $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules NYSEMkt Updated Jun 19, 2020 11:56 PM Caladrius Biosciences, Inc. Common Stock, also called Caladrius Biosciences, is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Share your opinion and gain insight from other stock traders and investors.